
Oral alitretinoin (9-cis retinoic acid) is an endogenous retinoid related to vitamin A. Studies have shown that oral alitretinoin is effective and well-tolerated in the treatment of severe chronic hand eczema, so that it is approved for this indication. This review summarizes new studies and clinical experience on the off-label use of alitretinoin.
Evidence-Based Medicine, Treatment Outcome, Drug-Related Side Effects and Adverse Reactions, Chronic Disease, Eczema, Humans, Tretinoin, Dermatologic Agents, Hand Dermatoses, Off-Label Use, Alitretinoin
Evidence-Based Medicine, Treatment Outcome, Drug-Related Side Effects and Adverse Reactions, Chronic Disease, Eczema, Humans, Tretinoin, Dermatologic Agents, Hand Dermatoses, Off-Label Use, Alitretinoin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
